Investigative Ophthalmology & Visual Science Cover Image for Volume 60, Issue 9
July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
The OBSERV platform (Ophthalmic Bioreactor Specialized in Experimental Research & Valorisation): an innovative ex vivo model of human herpetic keratitis.
Author Affiliations & Notes
  • Emilie COURRIER
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Victor LAMBERT
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
    University Hospital of Saint-Etienne, Department of Ophthalmology, Saint-Étienne, France
  • Corantin MAURIN
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Thomas BOURLET
    Groupe Immunité des Muqueuses et Agents Pathogènes, Jean Monnet University, Saint-Étienne, France
  • Paul VERHOEVEN
    Groupe Immunité des Muqueuses et Agents Pathogènes, Jean Monnet University, Saint-Étienne, France
  • Sana CHARAOUI-BOUKERZAZA
    Groupe Immunité des Muqueuses et Agents Pathogènes, Jean Monnet University, Saint-Étienne, France
  • Samy AL BOURGOL
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Emmanuel CROUZET
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Chantal PERRACHE
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Pascal HERBEPIN
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Zhiguo HE
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
  • Philippe Gain
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
    University Hospital of Saint-Etienne, Department of Ophthalmology, Saint-Étienne, France
  • Gilles Thuret
    Laboratory Biology, Engineering and Imaging of Corneal Grafts, Jean Monnet University, Saint-Étienne, France
    University Hospital of Saint-Etienne, Department of Ophthalmology, Saint-Étienne, France
  • Footnotes
    Commercial Relationships   Emilie COURRIER, None; Victor LAMBERT, None; Corantin MAURIN, None; Thomas BOURLET, None; Paul VERHOEVEN, None; Sana CHARAOUI-BOUKERZAZA, None; Samy AL BOURGOL, None; Emmanuel CROUZET, None; Chantal PERRACHE, None; Pascal HERBEPIN, None; Zhiguo HE, None; Philippe Gain, Laboratoires Thea (C), Quantel Medical (C), Sincler (C), University Jean Monnet (P); Gilles Thuret, Laboratoires Thea (C), Quantel Medical (C), Sincler (C), University Jean Monnet (P)
  • Footnotes
    Support  ANR Santé Bien-être FLUOCOR 2015 (ANR-15-CE18-0033) / BANCO : ANSM 2012 and EFS 2012 research grant / University Jean Monnet support
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3228. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Emilie COURRIER, Victor LAMBERT, Corantin MAURIN, Thomas BOURLET, Paul VERHOEVEN, Sana CHARAOUI-BOUKERZAZA, Samy AL BOURGOL, Emmanuel CROUZET, Chantal PERRACHE, Pascal HERBEPIN, Zhiguo HE, Philippe Gain, Gilles Thuret; The OBSERV platform (Ophthalmic Bioreactor Specialized in Experimental Research & Valorisation): an innovative ex vivo model of human herpetic keratitis.. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3228.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Our university lab BiiGC patented 2 versions of a bioreactor (BR): one for long-term eyebanking (in the process of industrialization), the other for preclinical experimentations, called OBSERV and supported by the French Agence Nationale de Sécurité du Médicament et des produits de Santé. Aim: to present an innovative ex vivo model of human herpetic keratitis (HSV-1).

Methods : By restoring intraocular pressure and medium renewal, the BR maintained the viability of human or animal corneas over a prolonged period. Its transparency allowed characterizing the tissue with existing or customized devices without compromising its sterility. Six corneas discarded after organ culture (OC) were placed in the BR for 14 days at 21mmHg and 5µL/H medium renewal. We previously showed that these 2 weeks allowed restoring a multilayered epithelium. The BR lid was opened for HSV inoculation: the epithelium was scarified and immersed for 1H in a solution of 105 to 106 Plaque-Forming Unit/mL HSV-1. The active storage was then continued for 3 to 6 days. Anti-HSV labeling was done on whole corneas maintained in the BR by incubating primary and secondary antibodies only with the epithelium. Comparison was made with OC cornea pairs infected in a concave support and incubated in OC without epithelial restoration step in the BR. Observations: on the whole cornea using a macroscope and, after flat-mounting, confocal microscopy. Corneas were also observed in transmission electronic microscopy (TEM).

Results : In the BR, pseudo-dendritic or geographic ulcers appeared. Immunostaining revealed infected epithelial cells and several areas with ulcers. Outside these spots, the epithelium remained multilayered. In several infected areas rounded and desquamating cells were observed. HSV-1 viral particles were observed by TEM. Two OC corneas had no epithelial cells at the beginning. In the 4 others that had only a few epithelial layers, viral lesions appeared as small “buds”. Controls without HSV remained unstained.

Conclusions : The OBSERV platform is an efficient tool to restore and maintain a multilayered epithelium on corneas discarded after OC, and allows HSV inoculation in more physiologic conditions than on a desquamated epithelium. The BR can complete or replace animal experimentation for academic or industrial research.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Corneas infected by HSV-1 in BR and in OC.

Corneas infected by HSV-1 in BR and in OC.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×